Intellectual property, pharmaceuticals and public health: access to drugs in developing countries

Shadlen Ken (), Guzman Alenka and N. Lalitha
Additional contact information
Shadlen Ken: LSE - London School of Economics and Political Science
Guzman Alenka: Universidad Autonoma Metropolitana - Iztapalapa
N. Lalitha: Gujarat Institute of Development Research

Post-Print from HAL

Keywords: Public health; drug accessibility; property rights; developing countries; globalization; governance.; TRIPS Agreement (search for similar items in EconPapers)
Date: 2011
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Published in Edward Elgar publishing, 2011

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01354917

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().